Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Julio A Lamprea-Montealegre"'
Autor:
Julio A. Lamprea-Montealegre, Abigail Shapiro, Natalie A.B. Bontrager, Dena E. Rifkin, Simerjot K. Jassal, Lucile Parker Gregg, Sankar D. Navaneethan, Krista Navarra, Michael G. Shlipak, Michelle M. Estrella, Virginia Wang
Publikováno v:
Kidney Medicine, Vol 6, Iss 6, Pp 100830- (2024)
Rationale & Objective: The measurement of cystatin C has been recommended to enhance chronic kidney disease (CKD) detection and risk stratification in clinical practice. This study gathered insights into the perceptions and experiences of clinical st
Externí odkaz:
https://doaj.org/article/ad736c15b7354506929f34b35ad8f394
Autor:
Julio A. Lamprea-Montealegre
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 43, Iss , Pp 101004- (2024)
Externí odkaz:
https://doaj.org/article/001b71c0659b4dc5bf676d33ad2d6f8a
Autor:
Kathleen Moloney, Julio A Lamprea Montealegre, Tania M Busch Isaksen, Mallory Kennedy, Megan Archer, Carlos Contreras, Daaniya Iyaz, Juliette Randazza, Javier Silva, Nicole A Errett
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0296851 (2024)
BackgroundAt the beginning of the COVID-19 pandemic, non-pharmaceutical interventions (NPIs) of unprecedented scope and duration were implemented to limit community spread of COVID-19. There remains limited evidence about how these measures impacted
Externí odkaz:
https://doaj.org/article/ddfef3bd19294f7caba17794f8cfb930
Autor:
Julio A. Lamprea-Montealegre, Priya Joshi, Abigail S. Shapiro, Erin Madden, Krista Navarra, O. Alison Potok, L. Parker Gregg, Tanya Podchiyska, Amy Robinson, Mary K. Goldstein, Carmen A. Peralta, Simerjot K. Jassal, Sankar D. Navaneethan, Dena. E. Rifkin, Virginia Wang, Michael G. Shlipak, Michelle M. Estrella
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background There are major gaps in the implementation of guideline-concordant care for persons with chronic kidney disease (CKD). The CKD Cascade of Care (C3) initiative seeks to improve CKD care by improving detection and treatment of CKD i
Externí odkaz:
https://doaj.org/article/56430e84ea5244afa72d7e2a780492d4
Autor:
Julio A. Lamprea‐Montealegre, Alice M. Arnold, Robyn L. McCLelland, Kenneth J. Mukamal, Luc Djousse, Mary L. Biggs, David S. Siscovick, Russell P. Tracy, Paul J. Beisswenger, Bruce M. Psaty, Joachim H. Ix, Jorge R. Kizer
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 15 (2022)
Background Advanced glycation endproducts (AGEs) have been linked to cardiovascular disease (CVD) in cohorts with and without diabetes. Data are lacking on prospective associations of various α‐dicarbonyl‐derived AGEs and incident CVD in the gen
Externí odkaz:
https://doaj.org/article/885ccc568011426bb09a4f00a37815f9
Autor:
Julio A. Lamprea‐Montealegre, Robyn L. McClelland, James D. Otvos, Samia Mora, Manja Koch, Majken K. Jensen, Ian H. de Boer
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 24 (2019)
Background Chronic kidney disease is associated with structural and compositional abnormalities in high‐density lipoprotein particles (HDLp). We examined associations of HDLp size, particle subfractions, and apolipoprotein C‐III content with inci
Externí odkaz:
https://doaj.org/article/50ee9e288bcf4526b7b39043e9c26781
Autor:
Julio A. Lamprea‐Montealegre, Leila R. Zelnick, Michael G. Shlipak, James S. Floyd, Amanda H. Anderson, Jiang He, Rob Christenson, Stephen L. Seliger, Elsayed Z. Soliman, Rajat Deo, Bonnie Ky, Harold I. Feldman, John W. Kusek, Christopher R. deFilippi, Myles S. Wolf, Tariq Shafi, Alan S. Go, Nisha Bansal
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 15 (2019)
Background We tested associations of cardiac biomarkers of myocardial stretch, injury, inflammation, and fibrosis with the risk of incident atrial fibrillation (AF) in a prospective study of chronic kidney disease patients. Methods and Results The st
Externí odkaz:
https://doaj.org/article/b279e959709d4c8a842e57beafa8b35d
Autor:
Julio A. Lamprea-Montealegre, Erin Madden, Sri Lekha Tummalapalli, Carmen Peralta, Torsten B. Neilands, Paola K. Garcia, Anthony Muiru, Leah Karliner, Michael G. Shlipak, Michelle M. Estrella
Publikováno v:
JAMA. 328(9)
ImportanceNovel therapies for type 2 diabetes can reduce the risk of cardiovascular disease and chronic kidney disease progression. The equitability of these agents’ prescription across racial and ethnic groups has not been well-evaluated.Objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c08326fc02beda80860af21e974ac4e0
https://pubmed.ncbi.nlm.nih.gov/36066540
https://pubmed.ncbi.nlm.nih.gov/36066540
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 3 (2018)
Externí odkaz:
https://doaj.org/article/e232a43152cd452d86dd737b4cda6516
Publikováno v:
Journal of the American College of Cardiology. 78:2493-2504
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07c2aa1ae371d07482953ffac8e5024a
https://doi.org/10.1016/j.jacc.2021.04.109
https://doi.org/10.1016/j.jacc.2021.04.109